Cargando...
Iatrogenic Cushing's syndrome and osteoporosis due to an interaction between fluticasone and ritonavir
The advent of highly active antiretroviral therapy for HIV infection dramatically changed the landscape of the disease. Ritonavir, a protease inhibitor (PI) frequently used in low doses to ‘boost’ the concentrations of other PIs, inhibits the cytochrome P450 3A4 isoenzyme, a common metabolic pathway...
Guardado en:
| Publicado en: | BMJ Case Rep |
|---|---|
| Autores principales: | , , , |
| Formato: | Artigo |
| Lenguaje: | Inglês |
| Publicado: |
BMJ Publishing Group
2015
|
| Materias: | |
| Acceso en línea: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4636689/ https://ncbi.nlm.nih.gov/pubmed/26516245 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1136/bcr-2015-211080 |
| Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|